Aromatherapy massage for pain and anxiety relief in ICU patients
Effect of Aromatherapy Massage Applıed to Intensıve Care Patıents on Physıologıcal Parameters, Paın, Anxıety and Intensıve Care Comfort
This study tests if aromatherapy massage with lavender, thyme, and eucalyptus can help reduce pain and anxiety for patients in the ICU.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 61 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Nigde Omer Halisdemir University Academic / other |
| Locations | 1 site (Nigde) |
| Trial ID | NCT06295874 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of aromatherapy massage using a blend of lavender, thyme, and eucalyptus oils on patients in the intensive care unit (ICU). It aims to alleviate pain, reduce anxiety, and enhance overall comfort for patients who are conscious and receiving oxygen therapy. The intervention involves administering the aromatherapy massage twice daily for three days to assess its impact on vital signs and comfort levels. The study utilizes specific assessment tools to measure outcomes related to pain and anxiety in the ICU setting.
Who should consider this trial
Good fit: Ideal candidates include conscious adults over 18 years old who have been in the ICU for at least 24 hours and are receiving oxygen therapy.
Not a fit: Patients with severe neurological impairments, open wounds, or those who are sedated or in delirium may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve the comfort and psychological well-being of ICU patients.
How similar studies have performed: While aromatherapy has been explored in various settings, this specific application in ICU patients is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years of age and over, * Conscious patients, * Staying in intensive care for 24 hours or more, * Those with stable hemodynamic status, * Receiving O2 therapy, * Intubated patients, patients who have passed 24 hours after being extubated, * Those whose saturation level is 85 and above Exclusion Criteria: * Patients with peripheral neuropathy or quadriplegia, * Patients with open wounds on their body, * Patients receiving analgesia and sedation infusion, * Patients who are sedated, * Patients in delirium, * Patients with an allergy detected before starting the application, * Patients with a GKS (Glasgow Coma Scale) score of 3 and below
Where this trial is running
Nigde
- Ömer Halisdemir University Training and Research Hospital — Nigde, Turkey (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.